首页> 外文期刊>BMC Medical Research Methodology >The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice
【24h】

The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice

机译:PRO-AGE研究:基于一般实践的国际老年人健康风险评估的随机对照研究

获取原文
           

摘要

Background This paper describes the study protocol, the recruitment, and base-line data for evaluating the success of randomisation of the PRO-AGE (PRevention in Older people – Assessment in GEneralists' practices) project. Methods/Design A group of general practitioners (GPs) in London (U.K.), Hamburg (Germany) and Solothurn (Switzerland) were trained in risk identification, health promotion, and prevention in older people. Their non-disabled older patients were invited to participate in a randomised controlled study. Participants allocated to the intervention group were offered the Health Risk Appraisal for Older Persons (HRA-O) instrument with a site-specific method for reinforcement (London: physician reminders in electronic medical record; Hamburg: one group session or two preventive home visits; Solothurn: six-monthly preventive home visits over a two-year period). Participants allocated to the control group received usual care. At each site, an additional group of GPs did not receive the training, and their eligible patients were invited to participate in a concurrent comparison group. Primary outcomes are self-reported health behaviour and preventative care use at one-year follow-up. In Solothurn, an additional follow-up was conducted at two years. The number of older persons agreeing to participate (% of eligible persons) in the randomised controlled study was 2503 (66.0%) in London, 2580 (53.6%) in Hamburg, and 2284 (67.5%) in Solothurn. Base-line findings confirm that randomisation of participants was successful, with comparable characteristics between intervention and control groups. The number of persons (% of eligible) enrolled in the concurrent comparison group was 636 (48.8%) in London, 746 (35.7%) in Hamburg, and 1171 (63.0%) in Solothurn. Discussion PRO-AGE is the first large-scale randomised controlled trial of health risk appraisal for older people in Europe. Its results will inform about the effects of implementing HRA-O with different methods of reinforcement.
机译:背景技术本文介绍了用于评估PRO-AGE(老年人的参与度-全科医生的实践评估)项目的随机化成功性的研究方案,募集和基线数据。方法/设计一组伦敦(英国),汉堡(德国)和索洛图恩(瑞士)的全科医生(GPs)接受了老年人风险识别,健康促进和预防的培训。他们的非残疾老年患者被邀请参加一项随机对照研究。分配给干预组的参与者获得了针对老年人的健康风险评估(HRA-O)仪器,该仪器采用了针对特定地点的强化方法(伦敦:电子病历中的医生提醒;汉堡:一组会议或两次预防性上门拜访;索洛图恩(Solothurn):为期两年的六个月预防性家访)。分配给对照组的参与者得到常规护理。在每个站点,另外一组全科医生没有接受培训,他们的合格患者被邀请参加同期比较组。主要结果是在一年的随访中自我报告的健康行为和预防性护理的使用。在索洛图恩,两年后又进行了一次随访。同意参加随机对照研究的老年人(占合格人口的百分比)在伦敦为2503(66.0%),在汉堡为2580(53.6%),在索洛图恩为2284(67.5%)。基线发现证实,参与者的随机分组是成功的,干预组和对照组之间的特征相当。同时参加比较组的人数(符合资格的人数)在伦敦为636(48.8%),在汉堡为746(35.7%),在索洛图恩为1171(63.0%)。讨论PRO-AGE是欧洲第一个针对老年人的健康风险评估的大型随机对照试验。其结果将告知采用不同加固方法实施HRA-O的效果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号